Detalles de la búsqueda
1.
Whole-breast irradiation with or without a boost for patients treated with breast-conserving surgery for early breast cancer: 20-year follow-up of a randomised phase 3 trial.
Lancet Oncol
; 16(1): 47-56, 2015 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-25500422
2.
FDG-PET-CT for staging of high-risk breast cancer patients reduces the number of further examinations: A pilot study.
Acta Oncol
; 49(2): 185-91, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20017664
3.
Prone breast irradiation for pendulous breasts.
Radiother Oncol
; 82(3): 337-40, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-16978722
4.
Radiation-induced bullous pemphigoid: a systematic review of an unusual radiation side effect.
Radiother Oncol
; 82(1): 5-9, 2007 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-17161479
5.
Effect of age and radiation dose on local control after breast conserving treatment: EORTC trial 22881-10882.
Radiother Oncol
; 82(3): 265-71, 2007 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-17126434
6.
Set-up verification and 2-dimensional electronic portal imaging device dosimetry during breath hold compared with free breathing in breast cancer radiation therapy.
Pract Radiat Oncol
; 5(3): e135-e141, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25432538
7.
The influence of the boost technique on local control in breast conserving treatment in the EORTC 'boost versus no boost' randomised trial.
Radiother Oncol
; 72(1): 25-33, 2004 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15236871
8.
Forward intensity-modulated radiotherapy planning in breast cancer to improve dose homogeneity: feasibility of class solutions.
Int J Radiat Oncol Biol Phys
; 82(1): 394-400, 2012 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21036489
9.
Is contrast enhancement required to visualize a known breast tumor in a pre-operative CT scan?
Radiother Oncol
; 100(2): 271-5, 2011 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-21741717
10.
Customized computed tomography-based boost volumes in breast-conserving therapy: use of three-dimensional histologic information for clinical target volume margins.
Int J Radiat Oncol Biol Phys
; 75(3): 757-63, 2009 Nov 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-19304402
11.
Impact of pathological characteristics on local relapse after breast-conserving therapy: a subgroup analysis of the EORTC boost versus no boost trial.
J Clin Oncol
; 27(30): 4939-47, 2009 Oct 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-19720914
12.
Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'.
Eur J Cancer
; 44(17): 2587-99, 2008 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18757193
13.
Impact of a higher radiation dose on local control and survival in breast-conserving therapy of early breast cancer: 10-year results of the randomized boost versus no boost EORTC 22881-10882 trial.
J Clin Oncol
; 25(22): 3259-65, 2007 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-17577015
Resultados
1 -
13
de 13
1
Próxima >
>>